1 Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden.
2 Department of Clinical Genetics, Uppsala University Hospital, Uppsala, Sweden.
3 Faculty of Pharmacy and 3P Medicine Laboratory, International Research Agendas Programme, Medical University of Gdańsk, Gdańsk, Poland.
4 Public Health Genomics, Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC, Australia.
5 Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden. jan.dumanski@igp.uu.se.
6 Faculty of Pharmacy and 3P Medicine Laboratory, International Research Agendas Programme, Medical University of Gdańsk, Gdańsk, Poland. jan.dumanski@igp.uu.se.
7 Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden. panagiotis.baliakas@igp.uu.se.
8 Department of Clinical Genetics, Uppsala University Hospital, Uppsala, Sweden. panagiotis.baliakas@igp.uu.se.
9 Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden. lars.forsberg@igp.uu.se.
10 The Beijer Laboratory, Uppsala University, Uppsala, Sweden. lars.forsberg@igp.uu.se.